BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- +10 vs. Q3 2025
- Shares held
- 57.9M
- +1.08M (+1.9%) vs. Q3 2025
- Total value
- $724.7M
- +$67.2M (+10.2%) vs. Q3 2025
- New holders
- 14
- 12 more added
- Sold out
- 4
- 12 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 300 | $3.76K | 0.00% | +300 | New |
| Rockefeller Capital Management L.P. | 700 | $8.76K | 0.00% | +700 | New |
| Bank of America Corp | 3,990 | $50.0K | 0.00% | +2,661+200.2% | Added |
| CIBC Private Wealth Group, LLC | 5,000 | $62.6K | 0.00% | +5,000 | New |
| Persistent Asset Partners Ltd | 8,585 | $107.5K | 0.05% | +8,585 | New |
| Squarepoint Ops LLC | 11,515 | $144.2K | 0.00% | +11,515 | New |
| Quadrature Capital Ltd | 12,922 | $161.8K | 0.00% | +12,922 | New |
| Morgan Stanley | 14,352 | $179.7K | 0.00% | +13,491+1,566.9% | Added |
| Point72 Asset Management, L.P. | 23,584 | $295.3K | 0.00% | +23,584 | New |
| BIT Capital GmbH | 25,000 | $313.0K | 0.01% | +25,000 | New |
| BNP Paribas Arbitrage, SA | 26,472 | $331.4K | 0.00% | +26,472 | New |
| XTX Topco Ltd | 28,633 | $358.5K | 0.01% | +5,249+22.4% | Added |
| Qube Research & Technologies Ltd | 35,952 | $450.1K | 0.00% | +35,952 | New |
| Manufacturers Life Insurance Company, The | 54,192 | $670.4K | 0.00% | +54,192 | New |
| Northern Trust Corp | 58,034 | $726.6K | 0.00% | −37,923−39.5% | Reduced |
| Boothbay Fund Management, LLC | 67,034 | $839.3K | 0.02% | −29,517−30.6% | Reduced |
| Renaissance Technologies LLC | 74,300 | $930.2K | 0.00% | +74,300 | New |
| StemPoint Capital LP | 86,517 | $1.08M | 0.19% | −100,097−53.6% | Reduced |
| UBS Group AG | 93,369 | $1.17M | 0.00% | +41,143+78.8% | Added |
| Goldman Sachs Group Inc | 94,651 | $1.19M | 0.00% | +94,651 | New |
| Moore Capital Management, LP | 100,000 | $1.25M | 0.03% | 00.0% | Unchanged |
| Woodline Partners LP | 103,707 | $1.30M | 0.01% | 00.0% | Unchanged |
| TD Asset Management Inc | 117,150 | $1.47M | 0.00% | −12,912−9.9% | Reduced |
| Sio Capital Management, LLC | 130,628 | $1.64M | 0.27% | 00.0% | Unchanged |
| State Street Corp | 218,278 | $2.73M | 0.00% | +41,583+23.5% | Added |
| Ikarian Capital, LLC | 220,231 | $2.76M | 0.36% | −25,000−10.2% | Reduced |
| ADAR1 Capital Management, LLC | 226,248 | $2.83M | 0.21% | −274,980−54.9% | Reduced |
| HighVista Strategies LLC | 229,263 | $2.87M | 0.74% | +229,263 | New |
| FMR LLC | 240,300 | $3.01M | 0.00% | +78,223+48.3% | Added |
| Millennium Management LLC | 241,415 | $3.02M | 0.00% | −128,148−34.7% | Reduced |
| Charles Schwab Investment Management Inc | 279,046 | $3.49M | 0.00% | −304−0.1% | Reduced |
| Casdin Capital, LLC | 282,312 | $3.53M | 0.22% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 561,987 | $7.04M | 0.00% | +20,385+3.8% | Added |
| Aisling Capital Management LP | 564,625 | $7.07M | 1.48% | 00.0% | Unchanged |
| Vanguard Group Inc | 791,095 | $9.90M | 0.00% | +143,496+22.2% | Added |
| Price T Rowe Associates Inc | 803,134 | $10.1M | 0.00% | −81,908−9.3% | Reduced |
| Armistice Capital, LLC | 1,000,000 | $12.5M | 0.31% | +588,000+142.7% | Added |
| Octagon Capital Advisors LP | 1,043,110 | $13.1M | 1.63% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,082,362 | $13.4M | 0.21% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,400,000 | $17.5M | 0.03% | −87,621−5.9% | Reduced |
| Laurion Capital Management LP | 1,464,938 | $18.3M | 1.25% | +419,138+40.1% | Added |
| Novo Holdings A/S | 1,961,317 | $24.6M | 1.91% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,084,837 | $26.1M | 0.00% | +36,285+1.8% | Added |
| Paradigm Biocapital Advisors LP | 2,261,749 | $28.3M | 0.76% | +395,608+21.2% | Added |
| Citadel Advisors LLC | 2,530,324 | $31.7M | 0.02% | −7,817−0.3% | Reduced |
| Enavate Sciences GP, LLC | 2,626,946 | $32.9M | 6.49% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,823,126 | $35.3M | 1.62% | 00.0% | Unchanged |
| Alphabet Inc. | 2,823,126 | $35.3M | 1.37% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,907,003 | $36.4M | 0.01% | −54,260−1.8% | Reduced |
| Omega Fund Management, LLC | 3,289,661 | $41.2M | 14.37% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 4,885,446 | $61.2M | 0.78% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 17,878,594 | $223.8M | 12.69% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −457,414−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −16−100.0% | Sold out |